• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

历史性天花疫苗接种与猴痘交叉反应性免疫:来自有儿童期和成年期接触史医护人员的证据

Historic smallpox vaccination and Mpox cross-reactive immunity: Evidence from healthcare workers with childhood and adulthood exposures.

作者信息

Galetti Sonja C, Gadoth Adva, Halbrook Megan, Tobin Nicole H, Ferbas Kathie G, Rimoin Anne W, Aldrovandi Grace M

机构信息

Department of Epidemiology, Jonathan and Karin Fielding School of Public Health, University of California, Los Angeles, California, USA.

Department of Pediatrics, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, CA, USA.

出版信息

Vaccine. 2025 Feb 6;46:126661. doi: 10.1016/j.vaccine.2024.126661. Epub 2025 Jan 2.

DOI:10.1016/j.vaccine.2024.126661
PMID:39752895
Abstract

In recent years, human mpox has made multiple resurges, prompting public health professionals to consider factors that lead to the increased risk for the reemergence of other orthopoxviruses. Due to the genetic similarity between orthopoxviruses, vaccinia vaccines used to prevent smallpox transmission are also indicated and have been used for mpox infection prevention and control. In this study, cross-reactive immunity for mpox was observed among individuals with self-reported history of smallpox vaccination. Differences in mean antigen response among individuals vaccinated in childhood and adulthood versus individuals vaccinated in childhood only were also observed, supporting the hypothesis that childhood smallpox vaccination may not be sufficient in providing long-lasting protection against multiple orthopoxviruses. These results provide insight on the durability of mpox immunogenic proteins and can be used to inform future studies to assess the benefits of reestablishing vaccinia vaccines as standard recommended immunizations, particularly where orthopoxviruses, such as mpox, are endemic.

摘要

近年来,人类猴痘多次卷土重来,促使公共卫生专业人员思考导致其他正痘病毒重新出现风险增加的因素。由于正痘病毒之间存在基因相似性,过去用于预防天花传播的牛痘疫苗也被证明可用于预防和控制猴痘感染。在本研究中,有天花疫苗接种史的个体中观察到了对猴痘的交叉反应性免疫。还观察到儿童期和成年期接种疫苗的个体与仅在儿童期接种疫苗的个体之间平均抗原反应的差异,这支持了以下假设:儿童期天花疫苗接种可能不足以提供针对多种正痘病毒的长期保护。这些结果为猴痘免疫原性蛋白的持久性提供了见解,可用于为未来的研究提供信息,以评估重新将牛痘疫苗作为标准推荐免疫接种的益处,特别是在猴痘等正痘病毒流行的地区。

相似文献

1
Historic smallpox vaccination and Mpox cross-reactive immunity: Evidence from healthcare workers with childhood and adulthood exposures.历史性天花疫苗接种与猴痘交叉反应性免疫:来自有儿童期和成年期接触史医护人员的证据
Vaccine. 2025 Feb 6;46:126661. doi: 10.1016/j.vaccine.2024.126661. Epub 2025 Jan 2.
2
The impact of orthopoxvirus vaccination and Mpox infection on cross-protective immunity: a multicohort observational study.正痘病毒疫苗接种和猴痘感染对交叉保护性免疫的影响:一项多队列观察性研究。
Lancet Microbe. 2025 Apr 28:101098. doi: 10.1016/j.lanmic.2025.101098.
3
Correlation between microneutralization test and a multiplexed immunoassay for evaluation of monkeypox and vaccinia virus antibodies before and after smallpox vaccination.在天花疫苗接种前后,用于评估猴痘病毒和牛痘病毒抗体的微量中和试验与多重免疫测定之间的相关性。
Front Immunol. 2025 Jun 23;16:1585284. doi: 10.3389/fimmu.2025.1585284. eCollection 2025.
4
Use of JYNNEOS (Smallpox and Mpox Vaccine, Live, Nonreplicating) for Persons Aged ≥18 Years at Risk for Mpox During an Mpox Outbreak: Recommendations of the Advisory Committee on Immunization Practices - United States, 2023.在猴痘疫情期间,为年龄≥18岁有猴痘感染风险人群使用JYNNEOS(天花和猴痘活病毒非复制疫苗):美国免疫实践咨询委员会的建议,2023年
MMWR Morb Mortal Wkly Rep. 2025 Jun 19;74(22):385-392. doi: 10.15585/mmwr.mm7422a3.
5
Immunogenicity of MVA-BN vaccine deployed as mpox prophylaxis: a prospective, single-centre, cohort study and analysis of transcriptomic predictors of response.作为猴痘预防措施使用的MVA-BN疫苗的免疫原性:一项前瞻性、单中心队列研究及反应的转录组预测因子分析。
Lancet Microbe. 2025 Jun;6(6):101045. doi: 10.1016/j.lanmic.2024.101045. Epub 2025 Apr 23.
6
Exploring monkeypox virus antibody levels: insights from human immunological research.探索猴痘病毒抗体水平:来自人体免疫学研究的见解
Virol J. 2025 May 31;22(1):175. doi: 10.1186/s12985-025-02748-0.
7
Safety and effectiveness of MVA-BN vaccination against mpox in at-risk individuals in Germany (SEMVAc and TEMVAc): a combined prospective and retrospective cohort study.德国高危人群中MVA-BN痘苗接种预防猴痘的安全性和有效性(SEMVAc和TEMVAc):一项前瞻性与回顾性队列联合研究
Lancet Infect Dis. 2025 Jul;25(7):775-787. doi: 10.1016/S1473-3099(25)00018-0. Epub 2025 Mar 18.
8
Characterization and comparison of immunity against MPXV for individuals infected with MPXV or vaccinated with modified vaccinia Ankara vaccines.感染猴痘病毒(MPXV)或接种安卡拉痘苗病毒(modified vaccinia Ankara)疫苗的个体对MPXV免疫的特征分析与比较
J Immunol. 2025 Feb 1;214(2):211-222. doi: 10.1093/jimmun/vkae031.
9
Willingness to take Mpox vaccine and associated factors among health professionals in Ethiopia: A cross-sectional study.埃塞俄比亚卫生专业人员接种猴痘疫苗的意愿及相关因素:一项横断面研究。
Vaccine. 2025 Mar 7;49:126822. doi: 10.1016/j.vaccine.2025.126822. Epub 2025 Jan 31.
10
Prescription of Controlled Substances: Benefits and Risks管制药品的处方:益处与风险